114 related articles for article (PubMed ID: 26901379)
1. The impact of retinol loading and surface charge on the hepatic delivery of lipid nanoparticles.
Pan TL; Wang PW; Hung CF; Aljuffali IA; Dai YS; Fang JY
Colloids Surf B Biointerfaces; 2016 May; 141():584-594. PubMed ID: 26901379
[TBL] [Abstract][Full Text] [Related]
2. Nanovesicle delivery to the liver via retinol binding protein and platelet-derived growth factor receptors: how targeting ligands affect biodistribution.
Hsu CY; Chen CH; Aljuffali IA; Dai YS; Fang JY
Nanomedicine (Lond); 2017 Feb; 12(4):317-331. PubMed ID: 28078954
[TBL] [Abstract][Full Text] [Related]
3. The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension.
Duong HT; Dong Z; Su L; Boyer C; George J; Davis TP; Wang J
Small; 2015 May; 11(19):2291-304. PubMed ID: 25641921
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis.
Hassan R; Tammam SN; Safy SE; Abdel-Halim M; Asimakopoulou A; Weiskirchen R; Mansour S
Eur J Pharm Biopharm; 2019 Jan; 134():96-106. PubMed ID: 30471341
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
[TBL] [Abstract][Full Text] [Related]
6. Zein/Phospholipid Composite Nanoparticles for Successful Delivery of Gallic Acid into aHSCs: Influence of Size, Surface Charge, and Vitamin A Coupling.
Radwan SAA; El-Maadawy WH; Yousry C; ElMeshad AN; Shoukri RA
Int J Nanomedicine; 2020; 15():7995-8018. PubMed ID: 33116514
[TBL] [Abstract][Full Text] [Related]
7. Silymarin-Loaded Nanoparticles Based on Stearic Acid-Modified Bletilla striata Polysaccharide for Hepatic Targeting.
Ma Y; He S; Ma X; Hong T; Li Z; Park K; Wang W
Molecules; 2016 Feb; 21(3):265. PubMed ID: 26938513
[TBL] [Abstract][Full Text] [Related]
8. Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy.
Zhang Z; Wang C; Zha Y; Hu W; Gao Z; Zang Y; Chen J; Zhang J; Dong L
ACS Nano; 2015 Mar; 9(3):2405-19. PubMed ID: 25587629
[TBL] [Abstract][Full Text] [Related]
9. In vivo real-time fluorescence visualization and brain-targeting mechanisms of lipid nanocarriers with different fatty ester:oil ratios.
Wen CJ; Yen TC; Al-Suwayeh SA; Chang HW; Fang JY
Nanomedicine (Lond); 2011 Nov; 6(9):1545-59. PubMed ID: 22077462
[TBL] [Abstract][Full Text] [Related]
10. A comparative study on the therapeutic effects of silymarin and silymarin-loaded solid lipid nanoparticles on D-GaIN/TNF-α-induced liver damage in Balb/c mice.
Cengiz M; Kutlu HM; Burukoglu DD; Ayhancı A
Food Chem Toxicol; 2015 Mar; 77():93-100. PubMed ID: 25544390
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles.
Jee JP; Lim SJ; Park JS; Kim CK
Eur J Pharm Biopharm; 2006 Jun; 63(2):134-9. PubMed ID: 16527470
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cytotoxicity and apoptosis-induced anticancer effect of silibinin-loaded nanoparticles in oral carcinoma (KB) cells.
Gohulkumar M; Gurushankar K; Rajendra Prasad N; Krishnakumar N
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():274-82. PubMed ID: 24907761
[TBL] [Abstract][Full Text] [Related]
13. Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis.
Kim BH; Yoon JH; Yang JI; Myung SJ; Lee JH; Jung EU; Yu SJ; Kim YJ; Lee HS; Kim CY
J Gastroenterol Hepatol; 2013 Dec; 28(12):1859-68. PubMed ID: 23808824
[TBL] [Abstract][Full Text] [Related]
14. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of BMP4 and Alpha Smooth Muscle Actin Expression in LX-2 Hepatic Stellate Cells by BMP4-siRNA Lipid Based Nanoparticle.
Omar R; Yang J; Alrushaid S; Burczynski FJ; Minuk GY; Gong Y
J Pharm Pharm Sci; 2018; 21(1):119-134. PubMed ID: 29578859
[TBL] [Abstract][Full Text] [Related]
16. Depletion of β-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway.
Sun WY; Song Y; Hu SS; Wang QT; Wu HX; Chen JY; Wei W
J Cell Biochem; 2013 May; 114(5):1153-62. PubMed ID: 23192415
[TBL] [Abstract][Full Text] [Related]
17. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model.
Shim SG; Jun DW; Kim EK; Saeed WK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
J Gastroenterol Hepatol; 2013 Dec; 28(12):1877-84. PubMed ID: 23808892
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of PTEN in hepatic tissue and hepatic stellate cells during rat liver fibrosis and its reversal.
Zheng L; Chen X; Guo J; Sun H; Liu L; Shih DQ; Zhang X
Int J Mol Med; 2012 Dec; 30(6):1424-30. PubMed ID: 23041795
[TBL] [Abstract][Full Text] [Related]
19. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
[TBL] [Abstract][Full Text] [Related]
20. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis.
Pastor M; Moreno-Sastre M; Esquisabel A; Sans E; Viñas M; Bachiller D; Asensio VJ; Pozo AD; Gainza E; Pedraz JL
Int J Pharm; 2014 Dec; 477(1-2):485-94. PubMed ID: 25445528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
